ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

Relevance of Neutralizing Antibodies for the Pharmacokinetics of Pegunigalsidase Alfa in Patients with Fabry Disease.

Malte Lenders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.